Company: DRTSW
Filing Date: 2025-04-28
Form Type: 424B5
Source: 0001213900-25-035799
Chunk: 50

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-04-28
Form: 424B5
Chunk 50
---
 the lawsuit was instituted in the foreign court; and                                          |

| ● | the judgment is enforceable according to the laws of Israel and according to the law of the foreign state 
 in which the relief was granted.                                                                          |

If a foreign judgment is enforced by an Israeli
court, it generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred out of
Israel. The usual practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli court
to issue a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on the date of the judgment, but the
judgment debtor may make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli
currency ordinarily will be linked to the Israeli consumer price index plus interest at the annual statutory rate set by Israeli regulations
prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.

<div align='center'>S-30

AUTHORIZED REPRESENTATIVE</div>

Our authorized representative in the United States
for this offering as required pursuant to Section 6(a) of the Securities Act is Alpha Tau Medical, Inc., 1 Union Street 3rd Floor,
Lawrence, MA 01840.

<div align='center'>S-31

WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION OF INFORMATION BY REFERENCE</div>

The SEC allows us to incorporate
by reference the information we file with them, which means that we can disclose important information to you by referring you to those
documents. The information incorporated by reference is considered to be part of this registration statement, and later information filed
with the SEC will update and supersede this information. We hereby incorporate by reference into this registration statement the following
documents previously filed with the SEC:

| ● | the description of our ordinary shares contained in our registration                                                                  
 statement on Form 8-A (File No. 001-41316), filed with the SEC on March 7, 2022, as updated by the description of our ordinary        
 shares that served as Exhibit 2.1 to our Annual Report on Form 20-F for the fiscal year ended December 31, 2024 filed with the SEC on 
 March 12, 2025.                                                                                                                       |

We have filed a registration
statement on Form F-3 to register the issuance and the resale of the securities described elsewhere in this prospectus supplement. This
prospect